Form 8-K - Current report:
SEC Accession No. 0001104659-25-078077
Filing Date
2025-08-14
Accepted
2025-08-14 07:11:02
Documents
14
Period of Report
2025-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2523408d1_8k.htm   iXBRL 8-K 27602
2 EXHIBIT 99.1 tm2523408d1_ex99-1.htm EX-99.1 82464
6 GRAPHIC tm2523408d1_ex99-1img001.jpg GRAPHIC 12073
  Complete submission text file 0001104659-25-078077.txt   302491

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lptx-20250814.xsd EX-101.SCH 3008
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lptx-20250814_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lptx-20250814_pre.xml EX-101.PRE 22354
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2523408d1_8k_htm.xml XML 3676
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37990 | Film No.: 251214276
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)